The recommended first-line pharmacological treatments for men with moderate to severe LUTS caused by benign prostatic hyperplasia are alpha-blockers, such as alfuzosin, doxazosin, tamsulosin, or terazosin. These are advised because of their rapid onset of action, good efficacy, and low rate of adverse events NICE CKS.
Review of men on alpha-blockers should occur at 4 to 6 weeks and then every 6 to 12 months, with re-assessment of symptoms and adverse effects NICE CKS.
If residual storage symptoms persist after alpha-blocker treatment, consider adding an antimuscarinic drug, such as oxybutynin, tolterodine, or darifenacin, or alternatively mirabegron if antimuscarinics are contraindicated or not tolerated NICE CKS.